United States Pharmaceuticals

Zevra Therapeutics Inc (ZVRA)

Track

Track

Zevra Therapeutics experienced net selling activity totaling approximately $138,377 over the past ninety days. Despite a positive earnings report, the stock price declined by 23%. Recent transactions involved four distinct insider sales, reflecting a trend of divestment among key personnel following the company's latest financial disclosures.
Ticker: ZVRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Zevra Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Thompson Rahsaan Chief Legal & Compliance Officer
Transaction date
Planned sale
Price
177.05
Quantity 13,303 -49.2%
Value US$4,316,930
RAHSAAN THOMPSON Officer; Secretary Officer
Transaction date
Proposed sale
Price
321.82
Quantity 28,460
Value US$2,887,324
2.6
Watton Corey Michael Non-Executive Director
Transaction date
Sale
Price
405.74
Quantity 98,859 -15.0%
Value US$4,530,644
3.4
JOHN BODE Director Non-Executive Director
Transaction date
Proposed sale
Price
14.85
Quantity 10,516
Value US$156,163
Thompson Rahsaan Chief Legal & Compliance Officer
Transaction date
Planned sale
Price
12.68
Quantity 34,557 -30.1%
Value US$438,304
Thompson Rahsaan Chief Legal & Compliance Officer
Transaction date
Planned sale
Price
11.30
Quantity 1,794 -3.6%
Value US$20,272
Rahsaan Thompson Officer; Chief Legal & Compliance / Secretary Officer
Transaction date
Proposed sale
Price
11.13
Quantity 36,351
Value US$404,587
3.6
RAYMOND L CLIFTON Officer Officer
Transaction date
Proposed sale
Price
9.87
Quantity 345,428
Value US$3,409,374
McFarlane Neil F. President and CEO Executive Director
Transaction date
Planned sale
Price
8.56
Quantity 14,625 -3.6%
Value US$125,186
3.1
Sangiovanni Timothy J. SVP, Finance & Corp Controller Officer
Transaction date
Planned sale
Price
9.18
Quantity 3,000 -9.2%
Value US$27,548
3.3
Schafer Joshua CCO Officer
Transaction date
Planned sale
Price
9.19
Quantity 10,500 -14.4%
Value US$96,500
NEIL F MCFARLANE Director; Officer Executive Director
Transaction date
Proposed sale
Price
9.00
Quantity 105,625
Value US$950,625
McFarlane Neil F. President and CEO Executive Director
Transaction date
Planned sale
Price
9.38
Quantity 91,000 -20.0%
Value US$853,425
Thompson Rahsaan Chief Legal & Compliance Officer
Transaction date
Planned sale
Price
8.83
Quantity 4,080 -7.6%
Value US$36,010
3.1
Sangiovanni Timothy J. SVP, Finance & Corp Controller Officer
Transaction date
Planned sale
Price
8.82
Quantity 1,750 -7.7%
Value US$15,442
3.3
Schafer Joshua CCO Officer
Transaction date
Planned sale
Price
8.83
Quantity 3,375 -8.3%
Value US$29,800
Quartel Adrian W Chief Medical Officer Officer
Transaction date
Planned sale
Price
8.83
Quantity 4,533 -31.8%
Value US$40,036
3.1
TIMOTHY SANGIOVANNI Officer Officer
Transaction date
Proposed sale
Price
8.86
Quantity 4,750
Value US$42,085
3.6
R LaDuane Clifton Former CFO & Treasurer
Transaction date
Proposed sale
Price
8.86
Quantity 14,000
Value US$124,040
RAHSAAN THOMPSON Officer; Secretary Officer
Transaction date
Proposed sale
Price
8.86
Quantity 4,080
Value US$36,149
3.3
JOSHUA SCHAFER Officer Officer
Transaction date
Proposed sale
Price
8.86
Quantity 13,875
Value US$122,932
ADRIAN QUARTEL Officer Officer
Transaction date
Proposed sale
Price
8.86
Quantity 4,533
Value US$40,162
NEIL F MCFARLANE Director; Officer Executive Director
Transaction date
Proposed sale
Price
10.82
Quantity 19,500
Value US$210,990
McFarlane Neil F. President and CEO Executive Director
Transaction date
Planned sale
Price
10.82
Quantity 19,500 -8.1%
Value US$210,908
3.7
FAVORITO TAMARA A Non-Executive Director
Transaction date
Purchase
Price
7.79
Quantity 3,175 +441.6%
Value US$24,718
3.0
Shih Alvin Non-Executive Director
Transaction date
Purchase
Price
7.89
Quantity 20,000 +inf%
Value US$157,800
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
9.17
Quantity 5,000 +12.5%
Value US$45,825
Thompson Rahsaan Chief Legal & Compliance Officer
Transaction date
Planned sale
Price
9.21
Quantity 24,000 -36.0%
Value US$221,004
RAHSAAN THOMPSON Officer; Secretary Officer
Transaction date
Proposed sale
Price
9.33
Quantity 24,000
Value US$223,920
2.6
Watton Corey Michael Non-Executive Director
Transaction date
Purchase
Price
7.84
Quantity 300 +20.0%
Value US$2,352
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
7.96
Quantity 10,000 +33.3%
Value US$79,624
McFarlane Neil F. President and CEO Executive Director
Transaction date
Planned sale
Price
8.05
Quantity 30,544 -13.8%
Value US$245,962
3.1
Sangiovanni Timothy J. SVP, Finance & Corp Controller Officer
Transaction date
Planned sale
Price
7.86
Quantity 3,000 -15.5%
Value US$23,588
McFarlane Neil F. President and CEO Executive Director
Transaction date
Planned sale
Price
7.86
Quantity 61,273 -21.6%
Value US$481,428
3.6
Clifton R. LaDuane CFO & Treasurer Officer
Transaction date
Planned sale
Price
7.86
Quantity 11,000 -17.6%
Value US$86,471
3.3
Schafer Joshua CCO & EVP, Bus. Development Officer
Transaction date
Planned sale
Price
7.86
Quantity 10,500 -26.3%
Value US$82,527
NEIL F MCFARLANE Director; Officer Executive Director
Transaction date
Proposed sale
Price
7.72
Quantity 91,817
Value US$708,827
3.6
R. LADUANE CLIFTON Officer Officer
Transaction date
Proposed sale
Price
7.72
Quantity 11,000
Value US$84,920
3.1
Timothy Sangiovanni Officer Officer
Transaction date
Proposed sale
Price
7.72
Quantity 3,000
Value US$23,160
3.3
Joshua Schafer Officer Officer
Transaction date
Proposed sale
Price
7.72
Quantity 10,500
Value US$81,060
2.6
Watton Corey Michael Non-Executive Director
Transaction date
Purchase
Price
7.92
Quantity 500 +50.0%
Value US$3,958
3.6
Clifton R. LaDuane CFO & Treasurer Officer
Transaction date
Purchase
Price
6.77
Quantity 2,000 +12.1%
Value US$13,540
3.2
Anderson Thomas Non-Executive Director
Transaction date
Purchase
Price
6.81
Quantity 10,000 +100.0%
Value US$68,065
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
5.87
Quantity 10,000 +50.0%
Value US$58,661
3.6
Clifton R. LaDuane CFO, Secretary & Treasurer Officer
Transaction date
Purchase
Price
4.96
Quantity 1,000 +7.0%
Value US$4,959
3.2
Anderson Thomas Non-Executive Director
Transaction date
Purchase
Price
4.88
Quantity 10,000 +inf%
Value US$48,764
3.3
Schafer Joshua CCO & EVP, Bus. Development Officer
Transaction date
Purchase
Price
5.13
Quantity 500 +16.7%
Value US$2,564
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
5.13
Quantity 10,000 +100.0%
Value US$51,333
2.6
Watton Corey Michael Non-Executive Director
Transaction date
Purchase
Price
5.95
Quantity 275 +37.9%
Value US$1,636
2.6
Watton Corey Michael Non-Executive Director
Transaction date
Purchase
Price
5.52
Quantity 325 +81.2%
Value US$1,794
2.6
Watton Corey Michael Non-Executive Director
Transaction date
Purchase
Price
5.11
Quantity 400 +inf%
Value US$2,042
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
5.05
Quantity 2,451 +32.5%
Value US$12,378
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
5.05
Quantity 100 +1.3%
Value US$504
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
5.04
Quantity 4,759 +176.9%
Value US$23,985
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
5.04
Quantity 1,000 +59.2%
Value US$5,040
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
5.04
Quantity 300 +21.6%
Value US$1,512
3.4
Bode John B Non-Executive Director
Transaction date
Purchase
Price
5.04
Quantity 1,390 +inf%
Value US$6,999
3.6
Clifton R. LaDuane CFO, Secretary & Treasurer Officer
Transaction date
Purchase
Price
4.95
Quantity 689 +5.3%
Value US$3,410
3.6
Clifton R. LaDuane CFO, Secretary & Treasurer Officer
Transaction date
Purchase
Price
4.95
Quantity 2,000 +18.1%
Value US$9,900
3.6
Clifton R. LaDuane CFO, Secretary & Treasurer Officer
Transaction date
Purchase
Price
4.94
Quantity 51 +0.5%
Value US$252
3.7
SEYMOUR TAMARA A Non-Executive Director
Transaction date
Purchase
Price
4.82
Quantity 519 +259.5%
Value US$2,502
3.3
Schafer Joshua CCO & EVP, Bus. Development Officer
Transaction date
Purchase
Price
4.61
Quantity 2,000 +inf%
Value US$9,218
3.1
Sangiovanni Timothy J. SVP, Corporate Controller Officer
Transaction date
Purchase
Price
4.14
Quantity 100 +2.3%
Value US$414
3.1
Sangiovanni Timothy J. SVP, Corporate Controller Officer
Transaction date
Purchase
Price
4.14
Quantity 1,100 +33.9%
Value US$4,554
3.6
Clifton R. LaDuane CFO, Secretary & Treasurer Officer
Transaction date
Purchase
Price
4.15
Quantity 1,725 +18.6%
Value US$7,159
3.6
Plooster Matthew R Non-Executive Director
Transaction date
Purchase
Price
4.20
Quantity 11,000 +146.7%
Value US$46,148
3.5
Pascoe Richard W Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.20
Quantity 10,000 +50.1%
Value US$41,978
2.9
Tierney David S Non-Executive Director
Transaction date
Purchase
Price
4.15
Quantity 5,000 +85.7%
Value US$20,732
3.6
Clifton R. LaDuane CFO, Secretary & Treasurer Officer
Transaction date
Purchase
Price
5.59
Quantity 25 +0.3%
Value US$140
3.6
Clifton R. LaDuane CFO, Secretary & Treasurer Officer
Transaction date
Purchase
Price
5.82
Quantity 610 +7.1%
Value US$3,550
3.5
Pascoe Richard W Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.44
Quantity 9,500 +90.7%
Value US$51,679
3.6
Clifton R. LaDuane CFO, Secretary & Treasurer Officer
Transaction date
Purchase
Price
5.98
Quantity 400 +5.2%
Value US$2,393
3.6
Clifton R. LaDuane CFO, Secretary & Treasurer Officer
Transaction date
Purchase
Price
5.98
Quantity 600 +8.4%
Value US$3,588
2.9
Tierney David S Non-Executive Director
Transaction date
Purchase
Price
4.39
Quantity 2,000 +52.2%
Value US$8,780
3.4
Mickle Travis C President & CEO Executive Director
Transaction date
Purchase
Price
4.39
Quantity 10,000 +967.1%
Value US$43,900
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-17 2026-08-14 PlS Planned sale
Thompson Rahsaan

Chief Legal & Compliance

Officer
13,303 -49.2%
177.05
US$4,316,930 		13,303 -49.2% 177.05 US$4,316,930
2026-08-14 2026-08-14 PrS Proposed sale
RAHSAAN THOMPSON

Officer; Secretary

Officer
28,460
321.82
US$2,887,324 		28,460 321.82 US$2,887,324
2026-08-12 2026-08-10 S Sale
2.6
Watton Corey Michael
Non-Executive Director
98,859 -15.0%
405.74
US$4,530,644 		98,859 -15.0% 405.74 US$4,530,644
2026-07-08 2026-07-08 PrS Proposed sale
3.4
JOHN BODE

Director

Non-Executive Director
10,516
14.85
US$156,163 		10,516 14.85 US$156,163
2026-06-23 2026-06-22 PlS Planned sale
Thompson Rahsaan

Chief Legal & Compliance

Officer
34,557 -30.1%
12.68
US$438,304 		34,557 -30.1% 12.68 US$438,304
2026-05-13 2026-05-11 PlS Planned sale
Thompson Rahsaan

Chief Legal & Compliance

Officer
1,794 -3.6%
11.30
US$20,272 		1,794 -3.6% 11.30 US$20,272
2026-05-11 2026-05-11 PrS Proposed sale
Rahsaan Thompson

Officer; Chief Legal & Compliance / Secretary

Officer
36,351
11.13
US$404,587 		36,351 11.13 US$404,587
2026-03-16 2026-03-16 PrS Proposed sale
3.6
RAYMOND L CLIFTON

Officer

Officer
345,428
9.87
US$3,409,374 		345,428 9.87 US$3,409,374
2026-02-10 2026-02-09 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
14,625 -3.6%
8.56
US$125,186 		14,625 -3.6% 8.56 US$125,186
2026-02-04 2026-02-03 PlS Planned sale
3.1
Sangiovanni Timothy J.

SVP, Finance & Corp Controller

Officer
3,000 -9.2%
9.18
US$27,548 		3,000 -9.2% 9.18 US$27,548
2026-02-04 2026-02-03 PlS Planned sale
3.3
Schafer Joshua

CCO

Officer
10,500 -14.4%
9.19
US$96,500 		10,500 -14.4% 9.19 US$96,500
2026-02-02 2026-02-02 PrS Proposed sale
NEIL F MCFARLANE

Director; Officer

Executive Director
105,625
9.00
US$950,625 		105,625 9.00 US$950,625
2026-02-02 2026-02-02 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
91,000 -20.0%
9.38
US$853,425 		91,000 -20.0% 9.38 US$853,425
2026-02-02 2026-01-30 PlS Planned sale
Thompson Rahsaan

Chief Legal & Compliance

Officer
4,080 -7.6%
8.83
US$36,010 		4,080 -7.6% 8.83 US$36,010
2026-02-02 2026-01-30 PlS Planned sale
3.1
Sangiovanni Timothy J.

SVP, Finance & Corp Controller

Officer
1,750 -7.7%
8.82
US$15,442 		1,750 -7.7% 8.82 US$15,442
2026-02-02 2026-01-30 PlS Planned sale
3.3
Schafer Joshua

CCO

Officer
3,375 -8.3%
8.83
US$29,800 		3,375 -8.3% 8.83 US$29,800
2026-02-02 2026-01-30 PlS Planned sale
Quartel Adrian W

Chief Medical Officer

Officer
4,533 -31.8%
8.83
US$40,036 		4,533 -31.8% 8.83 US$40,036
2026-01-30 2026-01-30 PrS Proposed sale
3.1
TIMOTHY SANGIOVANNI

Officer

Officer
4,750
8.86
US$42,085 		4,750 8.86 US$42,085
2026-01-30 2026-01-30 PrS Proposed sale
3.6
R LaDuane Clifton

Former CFO & Treasurer
14,000
8.86
US$124,040 		14,000 8.86 US$124,040
2026-01-30 2026-01-30 PrS Proposed sale
RAHSAAN THOMPSON

Officer; Secretary

Officer
4,080
8.86
US$36,149 		4,080 8.86 US$36,149
2026-01-30 2026-01-30 PrS Proposed sale
3.3
JOSHUA SCHAFER

Officer

Officer
13,875
8.86
US$122,932 		13,875 8.86 US$122,932
2026-01-30 2026-01-30 PrS Proposed sale
ADRIAN QUARTEL

Officer

Officer
4,533
8.86
US$40,162 		4,533 8.86 US$40,162
2025-10-10 2025-10-10 PrS Proposed sale
NEIL F MCFARLANE

Director; Officer

Executive Director
19,500
10.82
US$210,990 		19,500 10.82 US$210,990
2025-10-10 2025-10-10 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
19,500 -8.1%
10.82
US$210,908 		19,500 -8.1% 10.82 US$210,908
2025-09-16 2025-09-12 B Purchase
3.7
FAVORITO TAMARA A
Non-Executive Director
3,175 +441.6%
7.79
US$24,718 		3,175 +441.6% 7.79 US$24,718
2025-09-15 2025-09-12 B Purchase
3.0
Shih Alvin
Non-Executive Director
20,000 +inf%
7.89
US$157,800 		20,000 +inf% 7.89 US$157,800
2025-08-20 2025-08-19 B Purchase
3.4
Bode John B
Non-Executive Director
5,000 +12.5%
9.17
US$45,825 		5,000 +12.5% 9.17 US$45,825
2025-06-30 2025-06-26 PlS Planned sale
Thompson Rahsaan

Chief Legal & Compliance

Officer
24,000 -36.0%
9.21
US$221,004 		24,000 -36.0% 9.21 US$221,004
2025-06-26 2025-06-26 PrS Proposed sale
RAHSAAN THOMPSON

Officer; Secretary

Officer
24,000
9.33
US$223,920 		24,000 9.33 US$223,920
2025-03-31 2025-03-28 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
300 +20.0%
7.84
US$2,352 		300 +20.0% 7.84 US$2,352
2025-03-21 2025-03-19 B Purchase
3.4
Bode John B
Non-Executive Director
10,000 +33.3%
7.96
US$79,624 		10,000 +33.3% 7.96 US$79,624
2025-02-14 2025-02-14 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
30,544 -13.8%
8.05
US$245,962 		30,544 -13.8% 8.05 US$245,962
2025-02-14 2025-02-13 PlS Planned sale
3.1
Sangiovanni Timothy J.

SVP, Finance & Corp Controller

Officer
3,000 -15.5%
7.86
US$23,588 		3,000 -15.5% 7.86 US$23,588
2025-02-14 2025-02-13 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
61,273 -21.6%
7.86
US$481,428 		61,273 -21.6% 7.86 US$481,428
2025-02-14 2025-02-13 PlS Planned sale
3.6
Clifton R. LaDuane

CFO & Treasurer

Officer
11,000 -17.6%
7.86
US$86,471 		11,000 -17.6% 7.86 US$86,471
2025-02-14 2025-02-13 PlS Planned sale
3.3
Schafer Joshua

CCO & EVP, Bus. Development

Officer
10,500 -26.3%
7.86
US$82,527 		10,500 -26.3% 7.86 US$82,527
2025-02-13 2025-02-13 PrS Proposed sale
NEIL F MCFARLANE

Director; Officer

Executive Director
91,817
7.72
US$708,827 		91,817 7.72 US$708,827
2025-02-13 2025-02-13 PrS Proposed sale
3.6
R. LADUANE CLIFTON

Officer

Officer
11,000
7.72
US$84,920 		11,000 7.72 US$84,920
2025-02-13 2025-02-13 PrS Proposed sale
3.1
Timothy Sangiovanni

Officer

Officer
3,000
7.72
US$23,160 		3,000 7.72 US$23,160
2025-02-13 2025-02-13 PrS Proposed sale
3.3
Joshua Schafer

Officer

Officer
10,500
7.72
US$81,060 		10,500 7.72 US$81,060
2024-10-16 2024-10-11 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
500 +50.0%
7.92
US$3,958 		500 +50.0% 7.92 US$3,958
2024-07-17 2024-07-17 B Purchase
3.6
Clifton R. LaDuane

CFO & Treasurer

Officer
2,000 +12.1%
6.77
US$13,540 		2,000 +12.1% 6.77 US$13,540
2024-07-16 2024-07-16 B Purchase
3.2
Anderson Thomas
Non-Executive Director
10,000 +100.0%
6.81
US$68,065 		10,000 +100.0% 6.81 US$68,065
2024-07-15 2024-07-12 B Purchase
3.4
Bode John B
Non-Executive Director
10,000 +50.0%
5.87
US$58,661 		10,000 +50.0% 5.87 US$58,661
2023-09-06 2023-09-06 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
1,000 +7.0%
4.96
US$4,959 		1,000 +7.0% 4.96 US$4,959
2023-09-06 2023-09-06 B Purchase
3.2
Anderson Thomas
Non-Executive Director
10,000 +inf%
4.88
US$48,764 		10,000 +inf% 4.88 US$48,764
2023-09-06 2023-09-05 B Purchase
3.3
Schafer Joshua

CCO & EVP, Bus. Development

Officer
500 +16.7%
5.13
US$2,564 		500 +16.7% 5.13 US$2,564
2023-09-06 2023-09-05 B Purchase
3.4
Bode John B
Non-Executive Director
10,000 +100.0%
5.13
US$51,333 		10,000 +100.0% 5.13 US$51,333
2023-06-26 2023-06-23 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
275 +37.9%
5.95
US$1,636 		275 +37.9% 5.95 US$1,636
2023-06-13 2023-06-09 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
325 +81.2%
5.52
US$1,794 		325 +81.2% 5.52 US$1,794
2023-05-31 2023-05-30 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
400 +inf%
5.11
US$2,042 		400 +inf% 5.11 US$2,042
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
2,451 +32.5%
5.05
US$12,378 		2,451 +32.5% 5.05 US$12,378
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
100 +1.3%
5.05
US$504 		100 +1.3% 5.05 US$504
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
4,759 +176.9%
5.04
US$23,985 		4,759 +176.9% 5.04 US$23,985
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
1,000 +59.2%
5.04
US$5,040 		1,000 +59.2% 5.04 US$5,040
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
300 +21.6%
5.04
US$1,512 		300 +21.6% 5.04 US$1,512
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
1,390 +inf%
5.04
US$6,999 		1,390 +inf% 5.04 US$6,999
2023-05-18 2023-05-18 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
689 +5.3%
4.95
US$3,410 		689 +5.3% 4.95 US$3,410
2023-05-18 2023-05-18 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
2,000 +18.1%
4.95
US$9,900 		2,000 +18.1% 4.95 US$9,900
2023-05-18 2023-05-18 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
51 +0.5%
4.94
US$252 		51 +0.5% 4.94 US$252
2023-03-21 2023-03-17 B Purchase
3.7
SEYMOUR TAMARA A
Non-Executive Director
519 +259.5%
4.82
US$2,502 		519 +259.5% 4.82 US$2,502
2023-03-15 2023-03-14 B Purchase
3.3
Schafer Joshua

CCO & EVP, Bus. Development

Officer
2,000 +inf%
4.61
US$9,218 		2,000 +inf% 4.61 US$9,218
2023-03-13 2023-03-10 B Purchase
3.1
Sangiovanni Timothy J.

SVP, Corporate Controller

Officer
100 +2.3%
4.14
US$414 		100 +2.3% 4.14 US$414
2023-03-13 2023-03-10 B Purchase
3.1
Sangiovanni Timothy J.

SVP, Corporate Controller

Officer
1,100 +33.9%
4.14
US$4,554 		1,100 +33.9% 4.14 US$4,554
2023-03-13 2023-03-10 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
1,725 +18.6%
4.15
US$7,159 		1,725 +18.6% 4.15 US$7,159
2023-03-13 2023-03-09 B Purchase
3.6
Plooster Matthew R
Non-Executive Director
11,000 +146.7%
4.20
US$46,148 		11,000 +146.7% 4.20 US$46,148
2023-03-13 2023-03-09 B Purchase
3.5
Pascoe Richard W

Chief Executive Officer

Executive Director
10,000 +50.1%
4.20
US$41,978 		10,000 +50.1% 4.20 US$41,978
2023-03-13 2023-03-09 B Purchase
2.9
Tierney David S
Non-Executive Director
5,000 +85.7%
4.15
US$20,732 		5,000 +85.7% 4.15 US$20,732
2023-01-13 2023-01-13 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
25 +0.3%
5.59
US$140 		25 +0.3% 5.59 US$140
2023-01-13 2023-01-13 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
610 +7.1%
5.82
US$3,550 		610 +7.1% 5.82 US$3,550
2023-01-13 2023-01-13 B Purchase
3.5
Pascoe Richard W

Chief Executive Officer

Executive Director
9,500 +90.7%
5.44
US$51,679 		9,500 +90.7% 5.44 US$51,679
2022-10-03 2022-09-30 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
400 +5.2%
5.98
US$2,393 		400 +5.2% 5.98 US$2,393
2022-10-03 2022-09-30 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
600 +8.4%
5.98
US$3,588 		600 +8.4% 5.98 US$3,588
2022-05-26 2022-05-25 B Purchase
2.9
Tierney David S
Non-Executive Director
2,000 +52.2%
4.39
US$8,780 		2,000 +52.2% 4.39 US$8,780
2022-05-25 2022-05-25 B Purchase
3.4
Mickle Travis C

President & CEO

Executive Director
10,000 +967.1%
4.39
US$43,900 		10,000 +967.1% 4.39 US$43,900
Explore more

More insider trading research around Zevra Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America